Singapore Medical Device Register entry
Xela Rederm
An injectable implant based on hyaluronic acid in a syringe, combined with succinic acid, a Hyalual brand product whose product owner is Diaco Biofarmaceutici S.r.l. Registered in Singapore as a Class D medical device with GLO Pharma Pte Ltd as registrant and exclusive distributor.
Register facts
Register facts and labelling
Register facts are from the Health Sciences Authority's Singapore Medical Device Register listing. Labelling facts are from the manufacturer's packaging and brochure. Registration is a statement of fact and does not imply that HSA promotes or endorses the device.
| Device name | Diaco Hyalual Xela Rederm |
|---|---|
| Risk class | Class D |
| Registration number | MDPR260401X0003 |
| Date registered | 1 April 2026 |
| Product owner | Diaco Biofarmaceutici S.r.l (Hyalual brand) |
| Registrant | GLO PHARMA PTE. LTD. |
| Presentations (register) | 1.1%, 1.8% and 2.2%; 1 ml and 2 ml |
| Composition (label) | Hyaluronic acid 11, 18 or 22 mg/ml with succinic acid 16 mg/ml, in a pre-filled syringe |
| Supplied to (GLO policy) | Registered medical practitioners only |
Healthcare professionals
Full product information
Registered indications and treatment areas, composition by strength, the manufacturer's description of its mechanism, protocol, packaging, ordering and support.
Patients
Talk to a doctor
Xela Rederm is injected by a doctor. Suitability, the treatment plan and pricing are matters for a consultation. We can tell you which clinics we supply.